Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study

Overview of attention for article published in Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease, September 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

policy: 1 policy source
twitter: 4 X users

patent: 2 patents

Readers on

mendeley: 166 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

Bempedoic acid with ezetimibe for treating primary hypercholesterolaemia or mixed dyslipidaemia : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence (NICE) on 27 Nov 2020

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.